Our molecular docking platform for screening a drug’s ability to bind the HLA-B*57:01 variant was built upon our peptide-specific docking models using the three X-ray crystals 3VRI, 3VRJ, and 3UPR. The docking workflow is illustrated in Fig.1. Molecular docking was conducted using GLIDE...